Seqens Seqens

X

Digital content for CureVac

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
CureVac
Germany Flag
Country
Country
Germany
Address
Address
Paul-Ehrlich-Str. 15, 72076 Tübingen
Telephone
Telephone
+49 7071 9883 - 0

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.accesswire.com/854343/curevac-to-report-fourth-quarter-and-full-year-2023-financial-results-and-business-update-on-april-24-2024

ACCESSWIRE
18 Apr 2024

https://www.curevac.com/en/curevac-and-md-anderson-enter-strategic-collaboration-to-develop-novel-cancer-vaccines/

PRESS RELEASE
17 Apr 2024

https://www.accesswire.com/853474/curevac-and-md-anderson-enter-strategic-collaboration-to-develop-novel-cancer-vaccines

ACCESSWIRE
16 Apr 2024

https://www.curevac.com/en/curevac-announces-promising-phase-2-interim-data-from-seasonal-influenza-vaccine-development-program-in-collaboration-with-gsk/

PRESS RELEASE
05 Apr 2024

https://www.accesswire.com/850084/curevac-announces-promising-phase-2-interim-data-from-seasonal-influenza-vaccine-development-program-in-collaboration-with-gsk

ACCESSWIRE
04 Apr 2024

https://www.accesswire.com/viewarticle.aspx?id=822295&lang=en

ACCESSWIRE
05 Jan 2024

https://www.fiercebiotech.com/biotech/curevac-touts-interim-data-drop-win-gsk-partnered-covid-19-vax-despite-grade-3-adverse

Gabrielle Masson FIERCE BIOTECH
05 Jan 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/german-court-quashes-curevac-patent-after-challenge-by-biontech-2023-12-19/

REUTERS
20 Dec 2023

https://www.accesswire.com/viewarticle.aspx?id=803088&lang=en

ACCESSWIRE
14 Nov 2023

https://www.accesswire.com/viewarticle.aspx?id=798383&lang=en

ACCESSWIRE
01 Nov 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY